Annexon (ANNX) News
NASDAQ: ANNXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ANNX news summary
We found 6 recent headlines mentioning Annexon (ANNX): 1 in the past week and 5 in the past 30 days, most often from GlobeNewswire, Nasdaq, Seeking Alpha. ANNX is making an outsized move today, down 9.09% at $3.10, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)", was published by GlobeNewswire on Nov 17, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Annexon headlines
- Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)BRISBANE, Calif., Nov. 17, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at…GlobeNewswire
- Annexon, Inc. Reports Third Quarter 2026 Financial Results and Strategic Credit Facility of up to $200 millionAnnexon, Inc. reported its financial results for the third quarter ended September 30, 2026. The company held cash, cash equivalents and short-term investments of $213.4 million as of September 30,…NasdaqANNX, BF.A
- Annexon Biosciences GAAP EPS of -$0.25Seeking Alpha
- Annexon Reports Third Quarter 2026 Financial Results, Business Updates and Key Anticipated MilestonesDifferentiated C1q Platform Advances Two Registrational Programs with Blockbuster Potential, Driving Near-Term Value CatalystsGlobeNewswire
- Commit To Buy Annexon At $2, Earn 100% Annualized Using OptionsInvestors considering a purchase of Annexon Inc (Symbol: ANNX) stock, but cautious about paying the going market price of $4.13/share, might benefit from considering selling puts among the…Nasdaq
- Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)BRISBANE, Calif., Oct. 16, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at…GlobeNewswire